Drugdu.com expert's response:

Before exporting medical devices, suppliers often overlook file details related to compliance, information consistency, and local market adaptation. These issues can easily lead to customs delays, registration setbacks, or rejected applications. Common problems include:

1. Failing to match the correct type of export certificate

Different intended uses may require different FDA export certificates. For example, devices intended for clinical research may require a Certificate of Exportability under Section 802, while devices intended for further processing may only require a simple notification. Some companies mistakenly use a general Certificate to Foreign Government (CFG), which may not meet the regulatory requirements of the target market.

2. Missing special documents for unregistered products

When exporting unregistered medical devices to markets such as Singapore, companies may need to apply for approval under a Special Access Route (SAR) in advance. They must also keep complete traceability records as distribution evidence. Many suppliers overlook these approval documents, which may result in goods being detained.

3. Poor management of certification validity across markets

Under the EU IVDR framework, CE marking for IVD products must be kept up to date. Some suppliers fail to track changes in certificate validity and submit expired documents for customs clearance, leading to rejection by the target market.

4. GMP quality documents disconnected from actual operations

Some companies use generic templates for their GMP documentation, including quality manuals, procedures, SOPs, and record forms, without adapting them to their own product categories. This can create inconsistencies between written procedures and actual on-site operations, which may be judged as non-compliant during overseas audits.

5. Inconsistent key information across documents

Core information such as product name, model number, and batch number must remain consistent across registration forms, instructions for use, and test reports. Any inconsistency may cause regulators to question the authenticity of the documents and significantly prolong the review process.

6. Inaccurate local-language translation

For non-English-speaking or less commonly used language markets, simple machine translation is often not enough. If medical device terminology is not translated professionally, technical descriptions may be inaccurate, causing reviewers to misunderstand the product classification or intended use and request repeated corrections.

7. Misunderstanding local rules for obtaining export sales certificates

In some regions, Class I medical devices may be handled by municipal market supervision authorities, while Class II and Class III devices may require certificates issued by provincial drug regulatory authorities. Some suppliers apply through the wrong authority, delaying certificate issuance and missing shipping windows.

8. Failure to update document versions

Submitting outdated test reports or production qualification documents that do not reflect the latest changes may fail to meet current regulatory requirements in the target market, resulting in returned or rejected registration applications.